GLP-1 Telehealth Providers in Georgia

Yes. Georgia allows telehealth prescribing of GLP-1 medications like semaglutide and tirzepatide.

Georgia generally requires audio-visual consultations (video) for establishing new patient relationships, though follow-up visits may use other modalities.

Yes. Most major telehealth GLP-1 platforms serve Georgia, giving residents many options to compare.

Georgia Medicaid (Georgia Families program) covers GLP-1 medications for type 2 diabetes but does not broadly cover them for weight management alone. Coverage for obesity indications is very limited. If you have both type 2 diabetes and obesity, prior authorization may be possible. Contact your Georgia Medicaid managed care plan to confirm whether weight management is a covered indication.

After the FDA removed semaglutide from the drug shortage list in early 2025, 503B outsourcing facility compounding ended. Georgia-licensed 503A compounding pharmacies retain limited ability to prepare individual prescriptions. Availability has decreased since 2024. Ask your telehealth provider whether they can access 503A-compounded semaglutide for your prescription.

Georgia telehealth providers can prescribe GLP-1 medications without a referral. If using insurance, prior authorization is nearly always required. Cash-pay programs bypass this requirement. Most async platforms complete intake and provide a prescription decision within 24–72 hours.

The most affordable GLP-1 programs in Georgia are typically async telehealth platforms with lower consultation fees. Brand-name medications (Wegovy, Zepbound) run $1,000–$1,300 per month without insurance. Compounded injectable semaglutide, when available through licensed 503A pharmacies, has historically run lower. Check our Georgia comparison table for current program prices.